IGMPI India

The Federal Food, Drug and Cosmetic Act (FD&C Act) regulates the use of specific marketing claims for products regulated by the US Food and Drug Administration (FDA), which includes pharmaceutical products, medical devices and food supplements. According to their responsibilities and regulations it is understood that a product is considered as misbranded if it makes claims for which it does not have an approval or which it is unable to meet as defined.

Recently, USFDA has sent a warning letter to Prestige Chinese Teas Company. This is a dietary supplement company dealing with dietary products. The FDAs letter states that the company's many products are in violation of the FD&C Act as they make claims that are restricted to pharmaceutical products. As stated by the regulator, the company claims that their dietary products can reduce cholesterol.

In order to support their claim, the company uses keywords that are picked up by the search engine and the viewers are directed to the companys WebPages. For example, keywords like lowering cholesterol, cholesterol reducing tea, lowering cholesterol levels, cholesterol tea, triglycerides levels, green tea cholesterol, etc. Also, along with these claims there were other alleged infractions, which led the FDA to call these products as misbranded. FDA has demanded that within 15 days of receiving the warning letter, the company should cease its actions that are violating the Act.